期刊
ALZHEIMERS & DEMENTIA
卷 17, 期 4, 页码 629-640出版社
WILEY
DOI: 10.1002/alz.12228
关键词
Alzheimer' s disease; axonal damage; BACE1; basal forebrain; neurodegeneration; preclinical
The study identified a positive correlation between plasma BACE1 protein concentrations and AD biomarkers of neurodegeneration, suggesting a potential role of BACE1 in Alzheimer's disease progression.
Background Increased beta-secretase 1 (BACE1) protein concentration, in body fluids, is a candidate biomarker of Alzheimer's disease (AD).We reported that plasma BACE1 protein concentrations are associated with the levels of brain amyloid beta (Alpha beta) accumulation in cognitively healthy individuals with subjective memory complaint (SMC). Methods In 302 individuals from the same cohort, we investigated the cross-sectional and longitudinal association between plasma BACE1 protein concentrations and AD biomarkers of neurodegeneration (plasma t-tau and Neurofilament light chain (NfL), fluorodeoxyglucose-positron emission tomography (FDG-PET), brain volumes in the basal forebrain [BF], hippocampus, and entorhinal cortex). Results We report a positive longitudinal correlation of BACE1 with both NfL and t-tau, as well as a correlation between annual BACE1 changes and bi-annual reduction of BF volume. We show a positive association between BACE1 and FDG-PET signal at baseline. Conclusions The association between plasma BACE1 protein concentrations and BF atrophy we found in cognitively healthy individuals with SMC corroborates translational studies, suggesting a role of BACE1 in neurodegeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据